Samei Huda presents the findings of a new meta-analysis, which explores the prognostic significance of competing ways of defining and measuring brief psychotic episodes.
[read the full story...]Prognosis of brief psychotic episodes
40 Responses »
What do you want from your psychiatric medication?
John Baker presents a systematic review of preferences for medication-associated outcomes in mental disorders, which concludes that we just don’t know what value mental health service users place on the different outcomes that come from taking psychiatric medication.
[read the full story...]Charting the evolution of early intervention in psychosis
Raphael Underwood summarises a recent PSSRU report about the growth in use of early intervention in psychosis services, which highlights opportunities to promote recovery amid concerns on health care sustainability.
[read the full story...]Crisis intervention for severe mental illness: Cochrane call for more evidence
John Baker is struck by the lack of evidence for crisis intervention for people with severe mental illness, highlighted by a recently updated Cochrane systematic review.
[read the full story...]Commonly prescribed psychiatric drugs: do they work?
John Baker summarises a review of commonly prescribed medication that covers seven psychiatric drugs, including antidepressants, antipsychotics, benzodiazepines, amphetamines, methylphenidate and cholinesterase inhibitors.
[read the full story...]Does integrated care work for substance use and schizophrenia?
Ian Hamilton reviews a recent long-term US study of integrated care for people with a dual diagnosis of substance use and schizophrenia, which concludes that recovery is possible, but it takes time.
[read the full story...]Transcranial magnetic stimulation for schizophrenia
Joanne Wallace considers the findings of a new Cochrane systematic review on Transcranial Magnetic Stimulation (TMS) for schizophrenia.
[read the full story...]Group psychotherapies for schizophrenia
Tracey Roberts appraises a systematic review of group psychotherapies for schizophrenia, which includes group CBT, music therapy, art therapy and social skills training.
[read the full story...]Lithium for schizophrenia: Cochrane find lack of evidence to support its use
Raphael Underwood presents a new Cochrane review of lithium for schizophrenia, which assesses the use of lithium as a monotherapy and also in combination with antipsychotics.
[read the full story...]Microglial activity in psychosis and schizophrenia
Samei Huda summarises a small PET brain imaging study, which looks at two cohorts (Ultra High Risk of Psychosis v Controls and Schizophrenia v Controls) to compare relative levels of microglial activity.
[read the full story...]